317 related articles for article (PubMed ID: 6132943)
1. Effect of plasmapheresis and steroid treatment on thyrotropin binding inhibitory immunoglobulins in a patient with exophthalmos and a patient with pretibial myxedema.
Kuzuya N; DeGroot LJ
J Endocrinol Invest; 1982; 5(6):373-8. PubMed ID: 6132943
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of exophthalmos and pretibial myxoedema with plasmapheresis.
Dandona P; Marshall NJ; Bidey SP; Nathan A; Havard CW
Br Med J; 1979 Feb; 1(6160):374-6. PubMed ID: 581653
[TBL] [Abstract][Full Text] [Related]
3. [Results of high-dose intravenous immunoglobulin treatment of patients with pretibial myxedema and Basedow's disease. Preliminary findings].
Antonelli A; Saracino A; Agostini S; Alberti B; Melosi A; Gambuzza C; Avantaggiato G; Baschieri L
Clin Ter; 1992 Sep; 141(9 Pt 2):63-8. PubMed ID: 1281765
[TBL] [Abstract][Full Text] [Related]
4. [Studies on the radioreceptor assay of TSH: the properties of TSH-binding inhibitor immunoglobulins (TBII) in patients with Graves' disease (author's transl)].
Endo K
Nihon Naibunpi Gakkai Zasshi; 1979 Oct; 55(10):1261-74. PubMed ID: 228998
[TBL] [Abstract][Full Text] [Related]
5. Exophthalmos and pretibial myxoedema not responding to plasmapheresis.
Dandona P; Marshall N; Bidey S; Nathan AW; Havard CW
Br Med J; 1979 Sep; 2(6191):667-8. PubMed ID: 583030
[No Abstract] [Full Text] [Related]
6. Patient with monoclonal gammopathy, thyrotoxicosis, pretibial myxedema and thyroid-associated ophthalmopathy; demonstration of direct binding of autoantibodies to the thyrotropin receptor.
Tonacchera M; Costagliola S; Cetani F; Ducobu J; Stordeur P; Vassart G; Ludgate M
Eur J Endocrinol; 1996 Jan; 134(1):97-103. PubMed ID: 8590966
[TBL] [Abstract][Full Text] [Related]
7. Anti-bovine TSH antibodies in patients with Graves' disease and primary myxedema.
Cho BY; Shong YK; Lee HK; Koh CS; Min HK
Thyroidology; 1989 Apr; 1(1):31-7. PubMed ID: 2484905
[TBL] [Abstract][Full Text] [Related]
8. Graves' autoantibodies to extrathyroidal TSH receptor: their role in ophthalmopathy and pretibial myxedema.
Rotella CM; Alvarez F; Kohn LD; Toccafondi R
Acta Endocrinol Suppl (Copenh); 1987; 281():344-7. PubMed ID: 3475915
[No Abstract] [Full Text] [Related]
9. Exophthalmos, pretibial myxedema, osteoarthropathy syndrome associated with papillary fibroelastoma in the left ventricle.
Suzuki H; Shimura H; Haraguchi K; Harii N; Endo T; Hosaka S; Yoshii S; Tada Y; Onaya T
Thyroid; 1999 Dec; 9(12):1257-60. PubMed ID: 10646668
[TBL] [Abstract][Full Text] [Related]
10. Treatment of exophthalmos and pretibial myxoedema with plasmapheresis.
Kriss JP
Br Med J; 1979 Apr; 1(6171):1149-50. PubMed ID: 444981
[No Abstract] [Full Text] [Related]
11. Exophthalmos and pretibial myxoedema not responding to plasmapheresis.
Lewis RA; Slater N; Croft DN
Br Med J; 1979 Aug; 2(6186):390-1. PubMed ID: 486950
[No Abstract] [Full Text] [Related]
12. Immunoglobulin A class fibroblast antibodies in patients with Graves' disease and pretibial myxedema.
Arnold K; Metcalfe R; Weetman AP
J Clin Endocrinol Metab; 1995 Dec; 80(12):3430-7. PubMed ID: 8530579
[TBL] [Abstract][Full Text] [Related]
13. Orbital decompression in Graves' ophthalmopathy associated with pretibial myxedema.
Fatourechi V; Garrity JA; Bartley GB; Bergstralh EJ; Gorman CA
J Endocrinol Invest; 1993 Jun; 16(6):433-7. PubMed ID: 8370919
[TBL] [Abstract][Full Text] [Related]
14. Response to topical halcinonide following fractional carbon dioxide laser pretreatment in a pretibial myxedema patient.
Xu Y; Ma R; Cai Y; Zheng X
Indian J Dermatol Venereol Leprol; 2018; 84(6):763. PubMed ID: 29363626
[No Abstract] [Full Text] [Related]
15. Relationship of long-acting thyroid stimulator to pretibial myxedema.
Schermer DR; Roenigk HH; Schumacher OP; McKenzie JM
Arch Dermatol; 1970 Jul; 102(1):62-7. PubMed ID: 4925011
[No Abstract] [Full Text] [Related]
16. Pretibial myxedema: pathophysiology and treatment options.
Fatourechi V
Am J Clin Dermatol; 2005; 6(5):295-309. PubMed ID: 16252929
[TBL] [Abstract][Full Text] [Related]
17. Treatment-resistant elephantiasic thyroid dermopathy responding to rituximab and plasmapheresis.
Heyes C; Nolan R; Leahy M; Gebauer K
Australas J Dermatol; 2012 Feb; 53(1):e1-4. PubMed ID: 22309343
[TBL] [Abstract][Full Text] [Related]
18. Graves' ophthalmopathy and pretibial myxedema: pathogenesis and treatment.
Chang TC
J Formos Med Assoc; 1994 Mar; 93(3):185-90. PubMed ID: 7920055
[No Abstract] [Full Text] [Related]
19. TSH and TSH receptor antibody-binding sites in fibroblasts of pretibial myxedema are related to the extracellular domain of entire TSH receptor.
Chang TC; Wu SL; Hsiao YL; Kuo ST; Chien LF; Kuo YF; Change CC; Chang TJ
Clin Immunol Immunopathol; 1994 Apr; 71(1):113-20. PubMed ID: 8137554
[TBL] [Abstract][Full Text] [Related]
20. A case of pretibial myxedema associated with Graves' disease: an immunohistochemical study of serum-derived hyaluronan-associated protein.
Shishido M; Kuroda K; Tsukifuji R; Fujita M; Shinkai H
J Dermatol; 1995 Dec; 22(12):948-52. PubMed ID: 8648004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
